Abstract
Although hailed as a paradigm shift, the breast conservative treatment that emerged in the 1980s was in fact an extension of the Halstedian concept, wherein whole-breast irradiation (WBI) compensated for the limited surgery. Observations that 80–90% of breast recurrences after breast conservative surgery and WBI occur in the tumor bed questions the need for protracted elective WBI, and provides the rationale for accelerated-partial-breast irradiation (APBI) of small cancers without adverse features predisposing to multicentric recurrence. APBI can be given over a week with various external beam, intraoperative or brachytherapy (interstitial or MammoSite®) techniques. Since the approval of MammoSite® by the US FDA in May 2002, a surge of interest has been evident, with 4,000 cases treated using this technique in the past 2 years. Several phase II APBI brachytherapy studies show that 4 to 7-year breast control rates (95%), survival and cosmetic outcome obtained from more than 600 appropriately selected women are comparable to matched or historic controls receiving WBI. The 2 to 3-year interim results of two ongoing randomized trials do not show any early detriment with APBI. If mature results of randomized trials confirm equivalence of APBI to conventional WBI in selected women, it would mark a paradigm shift and a major advance in treatment. This would allow many more women to opt for breast conservation, resolve the dilemmas regarding chemotherapy and radiotherapy sequencing and perhaps would be more cost effective.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Clark RM et al. (1996) Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node negative breast cancer: an update. J Natl Cancer Inst 88: 1659–1664
Liljegren GG et al. (1999) 10 year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: A randomized trial. J Clin Oncol 17: 2326–2333
Veronesi U et al. (2001) Radiotherapy after breast conserving surgery in small breast carcinoma: Long-term results of a randomized trial. Ann Oncol 12: 997–1003
Arthur DW et al. (2003) Accelerated partial breast irradiation: an updated report from the American Brachytherapy Society. Brachytherapy 2: 124–130
Buchholz TA (2003) Partial breast irradiation–is it ready for prime time? Int J Radiat Oncol Biol Phys 57: 1214–1216
Bartelink H (2003) Radiotherapy to the conserved breast chest wall and regional nodes: Is there a standard? Breast 12: 475–482
Bartelink H (2004) Intraoperative radiotherapy for breast cancer: tail wagging the dog? Lancet Oncol 5: 207–208
McCormick BC (2003) The politics and the ethics of breast cancer. Brachytherapy 2: 119–120
Rose CM and Recht A (2003) Accelerated partial-breast irradiation (APBI): let's give it a good test. Int J Radiat Oncol Biol Phys 57: 1217–1218
Vicini FA et al. (2003) Inconsistency, perspective, double talk, and false virtue. Brachytherapy 2: 121–23
Vicini F et al. (2003) Defining the efficacy of accelerated partial breast irradiation: the importance of proper patient selection, optimal quality assurance, and common sense. Int J Radiat Oncol Biol Phys 57: 1210–1213
Wallner P et al. (2004) Workshop on partial breast irradiation: state of the art and the science, Bethesda, MD, December 8–10, 2002. J Natl Cancer Inst 96: 175–184
Morrow M et al. (2001) Factors predicting the use of breast-conserving therapy in stage I and II breast carcinoma. J Clin Oncol 19: 2254–2262
Tobias JS et al. (2004) Reducing radiotherapy dose in early breast cancer: the concept of conformal intraoperative brachytherapy. Br J Radiol 77: 279–284
Recht A et al. (1995) Sequencing of chemotherapy and radiotherapy following conservative surgery for patients with early stage breast cancer: results of a randomized trial [abstract]. Int J Radiat Oncol Biol Phys 32 (Suppl): S148
Polgar C et al. (2004) High dose rate brachytherapy alone versus whole breast radiotherapy with or without tumor bed boost after breast conserving surgery: Seven year results of a comparative study. Int J Radiat Oncol Biol Phys 60: 1173–1181
Kuske RR et al. (2004) A phase II trial of brachytherapy alone following lumpectomy for stage I or II breast cancer: Initial outcomes of RTOG 9517 [abstract]. J Clin Oncol 22: 18
Vaidya JS et al. (2004) Intraoperative radiotherapy for breast cancer. Lancet Oncol 5: 165–173
Vaidya JS et al. (1996) Multicentricity of breast cancer: whole organ analysis and clinical implications. Br J Cancer 56: 820–824
Pawlik TM et al. (2004) Potential applicability of balloon catheter-based accelerated partial breast irradiation after conservative surgery for breast carcinoma. Cancer 100: 490–498
Kuerer HM et al. (2003) The case for accelerated partial breast irradiation for breast cancer. Contemporary Surgery 59: 508–517
Kader HA et al. (2004) Is the breast postoperative seroma a reliable guide for planning accelerated partial breast irradiation [abstract]? Radioth Oncol 71 (Suppl 2): S39
Weed D et al. (2003) The validity of clips as a radiographic surrogate for the biopsy cavity in image-guided accelerated partial breast irradiation [abstract]. Int J Radiat Oncol Biol Phys 57(Suppl 2): S308
Vicini FA et al. (2001) Accelerated treatment of breast cancer. J Clin Oncol 19: 1993–2001
Polgar C et al. Brachytherapy for partial breast irradiation: The European experience. Sem Radiat Oncol, in press
Keisch M et al. (2004) Thirty month results with MammoSite® breast brachytherapy applicator: Cosmesis, toxicity and local control in partial breast irradiation [abstract]. Int J Radiat Oncol Biol Phys 60 (Suppl 1): S272
Richards GM et al. (2004) Acute toxicity of high-dose-rate intracavitary brachytherapy with the MammoSite applicator in patients with early-stage breast cancer. Ann Surg Oncol 11: 739–746
Arthur DW and Vicini FA (2004) MammoSite RTS: the reporting of initial experiences and how to interpret. Ann Surg Oncol 11: 723–724
Formenti SC et al. (2002) T1 stage breast cancer: Adjuvant hypofractionated conformal radiotherapy to tumor bed in selected postmenopausal breast cancer patients– pilot feasibility study. Radiology 222: 171–178
Vicini F et al. (2003) Ongoing clinical experience utilizing 3D conformal external beam radiotherapy to deliver partial-breast irradiation in patients with early-stage breast cancer treated with breast-conserving therapy. Int J Rad Oncol Biol Phys 57: 1247–1253
Magee B et al. (1996) Prognostic factors for breast recurrence after conservative breast surgery and radiotherapy: results from a randomized trial. Radioth Oncol 39: 223–227
Orecchia R et al. (2003) Intraoperative radiation therapy with electrons (ELIOT) in early stage breast cancer. Breast 12: 483–490
Edmundson GK et al. (2003) Accelerated treatment of breast cancer: Dosimetric comparison between interstitial HDR brachytherapy, Mammosite balloon brachytherapy, and external beam quadrant irradiation [abstract]. Int J Radiat Oncol Biol Phys 57 (Suppl 2): S307–S308
Streeter OE Jr et al. (2003) MammoSite radiation therapy system. Breast 12: 491–496
Das RK et al. (2004) 3D CT-based high-dose-rate breast brachytherapy implants: treatment planning and quality assurance. Int J Radiat Oncol Biol Phys 59: 1224–1228
Narayanan SS et al. (2003) Intraoperative high dose rate 192Ir radical implant in early breast cancer: A quality assurance and dosimetry study. Int J Radiat Oncol Biol Phys 56: 690–696
King TA et al. (2000) Long-term results of wide-field brachytherapy as the sole method of radiation therapy after segmental mastectomy for T(is,1,2) breast cancer. Am J Surg 180: 299–304
Arthur DW et al. (2003) Partial breast brachytherapy after lumpectomy: low-dose-rate and high-dose-rate experience. Int J Radiat Oncol Biol Phys 56: 681–689
Perera F et al. (2003) Patterns of breast recurrence in a pilot study of brachytherapy confined to the lumpectomy site for early breast cancer with six years' minimum follow-up. Int J Radiat Oncol Biol Phys 57: 1239–1246
Poti Z et al. (2004) Partial breast irradiation with interstitial 60CO brachytherapy results in frequent grade 3 or 4 toxicity. Evidence based on a 12-year follow-up of 70 patients. Int J Radiat Oncol Biol Phys 58: 1022–1033
The American Society of Breast Surgeons (online 30 April 2003) Consensus Statement for Accelerated Partial Breast Irradiation [http://www.breastsurgeons.org/officialstmts/officialstmt3.shtml] (accessed on 15 August 2004)
Ott OJ et al. (2004) Accelerated partial breast irradiation with 192-Iridium multicatheter PDR/HDR brachytherapy. 2 year results of the German Austrian multicenter trial [abstract]. Radioth Oncol 71 (Suppl 2): S38
Dowlatshahi K et al. (2004). Early experience with balloon brachytherapy for breast cancer. Arch Surg 139: 603–607
Shah NM et al. (2004) MammoSite and interstitial brachytherapy for accelerated partial breast irradiation: factors that affect toxicity and cosmesis. Cancer 101: 727–734
Fentiman IS et al. (1996) Inadequacy of Iridium implant as sole radiation treatment for operable breast cancer. Eur J Cancer 32A: 608–611
Berle L et al. Toxicity, local control and cosmesis after interstitial partial breast HDR brachytherapy alone for T1/T2 breast cancer [abstract]. Radioth Oncol 71 (Suppl 2): S37
Krishnan L et al. (2001) Breast conservation therapy with tumor bed irradiation alone in a selected group of patients with stage I breast cancer. Breast J 7: 91–96
Lawenda BD et al. (2003) Dose-volume analysis of radiotherapy for T1N0 invasive breast cancer treated by local excision and partial breast irradiation by low-dose-rate interstitial implant. Int J Radiat Oncol Biol Phys 56: 671–680
Dickler A et al. (2004) Treatment volume and dose optimisation of MammoSite breast brachytherapy applicator. Int J of Radiation Oncol Biol Phys 59: 469–474
Kassas B et al. (2004) Contrast effects on dosimetry of a partial breast irradiation system. Med Phys 31: 1976–1979
Hensley ML et al. (1999) American Society of Clinical Oncology clinical practice guidelines for the use of chemotherapy and radiotherapy protectants. J Clin Oncol 31: 3333–3355
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Glossary
- ELIOT
-
Electron Beam Intraoperative Radiotherapy
- TARGIT
-
Targeted intraoperative radiotherapy
Rights and permissions
About this article
Cite this article
Sarin, R. Partial-breast treatment for early breast cancer: emergence of a new paradigm. Nat Rev Clin Oncol 2, 40–47 (2005). https://doi.org/10.1038/ncponc0071
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncponc0071
This article is cited by
-
Comparison of subjective, objective and patient-reported cosmetic outcomes between accelerated partial breast irradiation and whole breast radiotherapy: a prospective propensity score-matched pair analysis
Breast Cancer (2020)
-
Brachytherapy in the treatment of breast cancer
International Journal of Clinical Oncology (2017)
-
Comparative dosimetric findings using accelerated partial breast irradiation across five catheter subtypes
Radiation Oncology (2015)
-
Ultra-targeted APBI using TARGIT—a cautionary note
Nature Reviews Clinical Oncology (2010)
-
A spreadsheet to determine the volume ratio for target and breast in partial breast irradiation*
Australasian Physics & Engineering Sciences in Medicine (2009)